Hannover Re’s Post

View organization page for Hannover Re, graphic

68,369 followers

"Unintended but expected consequences: a look at the rising trend in cancer claims in the wake of the pandemic." Four speakers explored this topic, and the role of newer technologies, during the first of Hannover Re South Africa’s seminars for 2024, co-hosted with Lancet Laboratories, a leading pathology laboratory operating in South Africa.   - Dr Arianna Alletzhauser, Head of Clinical Operations of Kaelo, presented on changes and potential implications given cancer screening trends in primary healthcare. The talk highlighted screening trends for cancer at the primary health care level, and the potential life insurance related insights that should be considered.   - Shevani Rijhumal, Head of Pricing and Research at Hannover Re South Africa, presented on “Claims Trends: Observations over the last decade and the impact of Covid.” The presentation gave insight into causes of claims, a view of trends and a global view, as well as considerations on the immediate and long term impact of COVID.   - Dr Allison Glass, Head: Molecular Pathology department of Lancet Laboratories, gave an update on Oncogenetics. The presentation looked at molecular assessment of tumours and the way certain tumours are being reclassified and the potential impacts this may have on underwriting, claims and policy wording.   - Petro Appelo, Head of New Business and Solutions at Hannover Re South Africa, presented on “Dynamic Health landscapes: Navigating life insurance solutions in this evolving environment.” The talk delved into strategies for staying ahead of the curve to ensure mutually beneficial outcomes – for insurers and policyholders alike - in an ever-changing health environment.   Thank you to our clients and partners for your attendance and active participation during the seminar!

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics